Maryland fire company hosts screenings as new study shows deadlier risk of certain cancers
But a recent study from the American Cancer Society (ACS) suggests certain cancers pose an even deadlier threat for firefighters.
These researchers stress the need for things like cancer screenings to help with detecting the cancer early enough for some kind of prevention.
These screenings are taking place at the Pikesville Volunteer Fire Company this week, thanks to a federal grant.
The study, published in the International Journal of Epidemiology last week, found an increased risk of mortality for most cancers in firefighters, but especially with kidney and skin cancers.
For kidney cancer, the study found firefighters had a 40% higher mortality rate than those who weren't firefighters.
For skin cancer, the mortality rate is 58% higher.
Howie Cohen, who always wanted to be a firefighter, has decades of experience under his belt.
"I mentioned it to a friend, and although I had a completely different career, I started volunteering," Cohen said.
The Pikesville Volunteer Fire Company is no stranger to a cancer diagnosis. Over the years, several members had died because of the disease.
That's why in 2018, Cohen wasn't surprised when he was diagnosed.
"I took a test here [at the firehouse]. We had one basic screening, just a blood test, and some markers came up for prostate cancer," Cohen said. "I knew it was coming. My numbers were going up."
Even though he's had surgery to remove his cancer, Cohen still looks to get screened when he can. It's why he signed up for a screening Monday at the PVFC firehouse on Sudbrook Lane.
Firefighters are 9% more likely to be diagnosed with cancer, as well as 14% more likely to die from cancer, according to research from the CDC and National Institute for Occupational Health and Safety.
The ACS stresses that screenings, like the one PVFC is hosting, are critical for prevention.
But, when cancer does surface, Cohen said, no matter what, the fire company rallies for each other.
"I had a traumatic injury last August, and from the time I was at the hospital until a month after I got home -- I almost had daily visitors from the firehouse," Cohen said. "I'd do the same thing for any other member. We had a member die of cancer three years ago now, and we were there every day."
A FEMA grant made this week's screenings at PVFC possible. The goal is to screen more than 50 active firefighters within the company.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Times
9 minutes ago
- New York Times
Have a Question About Death? A New Project May Have Answers.
Times Insider explains who we are and what we do and delivers behind-the-scenes insights into how our journalism comes together. Late last year, Amelia Pisapia confronted something she'd long been wrestling with. 'I was still holding a lot of grief around Covid,' said Ms. Pisapia, who spent the first year and a half of the pandemic assisting with resources for New York Times readers, such as a Covid-19-related explainer. 'With the five-year anniversary of Covid coming up, I was looking for a place to put that grief.' Ms. Pisapia, an editor on The Times's Projects and Initiatives team, pitched a series to her team titled 'Death in the Modern Age.' It would focus on end-of-life issues and serve as a resource for readers who might be grappling with their own mortality or coping with the loss of someone close to them. The first article in the series was about A.I. 'griefbots,' written by Colin Dickey, a writer whose work deals with the occult in America. The cornerstone of the project is an F.A.Q. titled 'Let's Talk About Death,' compiled from several hundred submissions from Times readers who either asked questions related to death and dying or shared personal experiences. It covers a spate of topics, from how to pay for end-of-life care to whether there is evidence of an afterlife. The F.A.Q. remains open, encouraging readers to continue submitting questions. 'There's no topic more evergreen than death,' Ms. Pisapia said. She added: 'Given reader interest and that it touches everyone, and every desk, we're hoping to keep it going.' In an interview last month, she discussed her goals for the project and the reader questions that have resonated with her the most. This interview has been condensed and edited. Tell us more about how this project came together. At this moment in the United States, there are a lot of people rethinking what they want in end-of-life care — whether because of the pandemic, finances, newly approved medical aid in dying laws, being a member of the so-called sandwich generation and caring for dying parents while raising children, or simply just wanting something different than a traditional funeral or burial. Want all of The Times? Subscribe.
Medscape
10 minutes ago
- Medscape
How Ancestral Plant Knowledge Could Shape Modern Medicine
"My registered name is Hemerson Dantas dos Santos, but you can add 'Pataxó Hãhãhãi' at the end, which is the Indigenous people I belong to." This is how the interview began, conducted by Medscape's Portuguese edition , with the researcher behind a study that catalogued 175 medicinal plants used by the Pataxó Hãhãhãi people from southern Bahia, Brazil. Of these plants, 43 are specifically used to treat the three most common health issues at the community's health center: diabetes, hypertension, and intestinal worms. Published in the Journal of Ethnobiology and Ethnomedicine , the study bridges traditional knowledge with contemporary scientific evidence. Notably, the work was led entirely by an Indigenous ethnobotanist — from planning to data collection in the field — with the goal of recovering and documenting his people's medicinal knowledge. Pataxó Hãhãhãi is a doctoral candidate at the Institute of Environmental, Chemical, and Pharmaceutical Sciences at the Federal University of São Paulo (UNIFESP), under the supervision of Eliane Rodrigues, professor at the institute's Center for Ethnobotanical and Ethnopharmacological Studies. He holds a degree in chemistry from the State University of Santa Cruz and a master's degree in organic chemistry from the Federal University of Bahia. The grandson of a tribal chief, Pataxó Hãhãhãi had only left the village a few times before enrolling at university; one such occasion was when he broke his arm and had to seek medical care. His university experience, combined with his daily life in the village, proved to be an invaluable asset in his research. The study follows the principles of "participatory ethnobotany," an approach that centers the population being studied in the scientific process. This method promotes the active involvement of traditional peoples in knowledge production. In this sense, Pataxó Hãhãhãi moves between two worlds — the forest and academia — with a firm footing in both. During his research, he explored his own family history and the historical violence faced by the Pataxó Hãhãhãi people. Expelled from their land in 1948, they only returned in 1982, which hindered the transmission of knowledge about medicinal plants and led to the loss of native species. Much of the land was turned into pasture, and Indigenous people began using nonnative plants in their practices. The traditional language was also lost. Today, the Pataxó Hãhãhãi people number around 3600 individuals across 10 villages. According to Pataxó Hãhãhãi, one of the key insights of the research was understanding the profound cultural and environmental losses experienced by the community. The introduction of diseases like diabetes and hypertension, conditions previously unknown in traditional Indigenous medicine before contact with non-Indigenous populations, presents further challenges. The low involvement of younger generations in traditional practices exacerbates these difficulties. For the research, Pataxó Hãhãhãi interviewed 19 individuals from the 10 villages, selected using the "snowball" method, where community members recommended who should be interviewed based on their reputation as healers. Participants were aged between 50 and 85, with 84% over the age of 62. Although many participants still use medicinal plants, most are now evangelical. Traditional healing rituals have given way to Christian prayers, Bible readings, and psalms. During the research, Pataxó Hãhãhãi collected plant samples recommended by the community's experts and compiled data on them from both traditional knowledge and academic literature. Of the 43 plants assessed for the most common health complaints, 79% had their use supported by scientific studies. He reviewed original articles and systematic reviews published in English over the past two decades, analyzing efficacy and safety data. 'This work was done by us and for us. It recovers knowledge that was being lost and shows that we can do science without abandoning our identity,' Pataxó Hãhãhãi said. In the following conversation with Medscape's Portuguese edition , Pataxó Hãhãhãi discussed the importance of preserving ancestral knowledge, reflected on the difference between external researchers and those embedded within the community and shared more details about his journey. How did a curious village boy become a doctoral student at one of Brazil's most prestigious universities? My parents and teachers always encouraged me to study, and due to my curiosity, my teachers at the village school guided me to study chemistry. I entered university through the national high school examination (Exame Nacional do Ensino Médio), but at first, I felt isolated and got poor grades. After I started spending more time in the library, I began to enjoy the theory more and was able to graduate. At the end of my course, I did scientific initiation with medicinal plants and began to see connections to my origins, but my advisor didn't accept that I study plants from the village. I was upset at the time, but today I understand her concern. Why was that? Research involving Indigenous peoples in Brazil is highly bureaucratic. Even though I lived in the village, it took me nearly a year to get approval from the National Foundation for Indigenous Peoples to conduct the study. I began my doctoral program at the start of the pandemic, attending online classes directly from the village. When I completed the theoretical part, in-person classes resumed, and I started fieldwork. Did the knowledge you brought from village life help in your academic journey? It helped a lot during my undergraduate studies; the inspiration and determination to keep going were crucial. But it took many hours and a lot of coffee to build a solid academic foundation. Every new subject felt like opening a door to new knowledge. I entered through the quota system, and at that time, I was the only Indigenous student at the university. Today, there are more Indigenous students, but the numbers are still small. Is Indigenous knowledge valued at the university, or do you feel that the two worlds — academic and Indigenous — remain disconnected? The two worlds are still somewhat isolated. However, some projects are attempting to bring the university closer to the schools in the villages, though these initiatives are not very strong yet. I know that much Indigenous knowledge is present in the university, but it is rarely recognized as such. Can you give an example of this? A significant portion of modern medicines is based on natural substances discovered through Indigenous practices. Researchers visited these communities, learned about these remedies, and brought the knowledge to universities. However, this knowledge is often explored without acknowledging its Indigenous origins, making it difficult to trace back to the communities that developed it. In the article, I focused on the distinction between external researchers and those embedded within the community. Since the 1970s, there has been an ongoing discussion about the need to properly value the knowledge of local peoples. Unfortunately, this issue still persists today. Do you consider yourself an insider or outsider researcher, or someone who navigates between the village and the university? I started as a chemistry researcher, studying the traceability of coffee types using analytical techniques, but this work wasn't connected to my Indigenous roots. Although my advisor wanted me to continue down that path, I chose to return to my community to apply knowledge locally. When I discovered ethnobotany, I realized it was exactly what I needed, and I began working with professor Eliane Rodrigues from UNIFESP. Do you believe there is an Indigenous science perspective, with its own ways of thinking and specific methodologies? For many academics, Indigenous science is already science in its rawest form. It's about observing nature, creating a hypothesis, testing it, and seeing the results — that's essentially what Indigenous people do. The difference is that these hypotheses often come from dreams, rituals, or memories of the elders. It's a very close relationship with nature. My experience involves a way of living that goes beyond visual and sensory perception, including a spiritual dimension. That's why you can't say both are the same. Do you believe both forms of science can coexist and complement each other? Yes, definitely. In academic science, for example, it's very difficult to go into the forest and test all the plants to discover a remedy because there are so many. But if you already have a clue, things change. You can focus on a specific family or genus, making the search more precise. That clue is intuitive, and for intuition to work, the person must have a deep connection with nature. How do Indigenous medicine and academic medicine coexist in your village? I still feel the integration between the two is weak, despite the health system being present in the village. During my research, the Indigenous Health Department established a medicinal plant garden here, which has been one of the most significant steps towards integrating knowledge. Additionally, we have an Indigenous doctor in the village, which greatly aids this integration. He combines his traditional knowledge with conventional therapies, recommending both when a health issue can be treated with a plant. You had the support of Indigenous leaders to begin this research. What are their main interests: preserving knowledge, deepening traditional knowledge through academia, or both? The goal was more about valuing knowledge. Here in the village, we know the value of plant and cultural knowledge, but because it's part of daily life, many people don't realize its importance. It's like drinking water: You know it's essential, but because it's so routine, we take it for granted. Today, many young people are more connected to the internet and social media, and they drift away from the knowledge passed down by the elders, shared through conversation, and lived experience. Gradually, this knowledge is being lost. But my work promotes an interaction between me, a young person, and the elders. I talk with them and take notes, so that this knowledge, once documented, can transcend time more easily. It's also crucial to encourage other young people to do the same. Another important point from the leaders is that Indigenous people who leave the village to study at universities bring back outside knowledge that can strengthen the community, rather than creating a separation from it. What difficulties did you face in studying medicinal plants? One of the biggest challenges was noticing that many plants, which were once abundant, are now hard to find. Some only grew in specific parts of the forest that have been destroyed. Today, many plants from outside the region have been introduced by Indigenous people who were displaced or by land grabbers. Many of the plants we find now are not native. Studying native plants is crucial because they are rarely studied, while nonnative plants have generally been well researched. The village is large and spans different biomes (Atlantic Forest and Caatinga), each with its own unique vegetation. As a result, people living in different parts of the village are familiar with different plants, and this knowledge doesn't always circulate across the community. How are the studies progressing now? My research is still ongoing. I expect to finish in 6 or 7 months. I decided to prioritize studying plants used to treat hypertension, intestinal worms, and diabetes, as these are the most common health concerns among Indigenous people today. By sharing this knowledge, I hope more community members can benefit. I am now finishing the section on plants used for other health complaints. Since I could identify many plants by their scientific names, I researched how they are used outside of our culture and compared that with our traditional knowledge. For those with related studies, the traditional use was confirmed by the known chemical composition of these plants. I would love to continue studying plants, but I'm still refining some ideas. I'm not sure what I'll do after this phase, but I know I want to pursue a path that strengthens my people. One possibility is to continue in academia, conducting research, and increasing Indigenous presence in higher education. I hope to bring Indigenous perspectives into the university, like painting it with jenipapo and urucum. Do you think the way forward is to study the plants or their chemical components? I don't focus much on isolating substances from plants because many others already do that. I believe that using the plants in their traditional form is a better approach. The elders possess great wisdom in how to use plants, and understanding their chemical properties only strengthens that knowledge. Today, I consider myself more of an ethnobotanist than a chemist. But herbs can't be studied the same way as isolated chemical substances, right? For instance, you couldn't conduct a placebo-controlled study with plants, could you? It's more complicated because studying plants involves far more variables than isolating a single substance. However, there are biological tests that start with plant extracts using simple methods. From there, evidence is gathered to determine if a plant can help with a specific health issue, potentially leading to the development of a medicine. A little-discussed aspect is the issue of contraindications and side effects. How do you address this? Generally, side effects of plants are understood as those that appear in the short term. If someone takes too much of a plant and feels unwell, they know the dose isn't right. The issue arises with prolonged use, which is harder to assess because the effects may not be easily identifiable. This is why laboratories can play a key role in strengthening knowledge about the safety of using these plants. Another important consideration is drug interactions. Using multiple plants or combining them with pharmaceutical medications isn't always advisable due to these interactions. I also observed that different Indigenous people would use the same name for different plants or the same name for different species. This is an important detail that often goes unnoticed but can affect the accuracy of plant identification. The project also includes a booklet with traditional recipes, correct? Yes, the manual will feature images, data, and some recipes shared by the elders. It's crucial to note that the method of preparing a remedy varies depending on experience. For someone experienced, it's one thing; for someone less familiar, it's another. Great care is needed in preparation. When you leave the village, do you usually take herbs with you, or do you prefer to go to a pharmacy if you need treatment? It depends on the issue, but I typically have both options. During my studies, I often returned home with a backpack full of bark, leaves, and roots. My mother would prepare teas for various ailments. If something required more, I'd first look for phytotherapy at the pharmacy. If I couldn't find it, I'd use synthetic medications. Having both options has always been better than relying on just one. Do you think there can be a harmonious integration of both forms of medicine? Based on the conversations I've had, I believe integration will improve. However, it's still a significant political challenge. True integration requires investment, building appropriate spaces, and acquiring equipment. It's not easy. I'm hopeful we'll progress, but for now, it remains a work in progress.
Entrepreneur
10 minutes ago
- Entrepreneur
Building a Healthier Future Through Technology and Inclusion
What began as a challenging experience soon sparked a lifelong mission to protect patients, empower clinicians, and eliminate preventable deaths. Opinions expressed by Entrepreneur contributors are their own. You're reading Entrepreneur Asia Pacific, an international franchise of Entrepreneur Media. On your mark, get set, go.. Joe Kiani, Masimo founder, Executive Chairman of Willow and serial entrepreneur, reminisced fondly of memories of he and his sister racing through their neighborhood streets of Shiraz. That was before his sister's surgery. "After that, she couldn't even run," said Kiani Watching his sister struggle to walk again after her procedure was the first of his many exposures to a healthcare system that failed the people it was meant to serve. That moment, according to Kiani, changed everything. What began as a challenging experience soon sparked a lifelong mission to protect patients, empower clinicians, and eliminate preventable deaths. Today, Kiani is the founder and Executive Chairman of Willow, a startup focused on empowering people to change the trajectory of their health and lives through preventative healthcare. He's also a fierce advocate for health equity, inclusion, and transparency in medicine. But behind his innovations is a deeply personal journey, a story rooted in grit, perseverance, and the pursuit of purpose over profit. From Shiraz to Silicon Valley Born in Shiraz, Iran, Kiani immigrated to the United States with his family at age nine. They arrived with limited English, few resources, and a fierce determination to build a better life. The cultural and linguistic barriers were significant, but Kiani adapted quickly, fueled by an insatiable curiosity and passion for people. He became obsessed with electronics and by high school, was designing gadgets and circuit boards. At just 15, he began studying electrical engineering at San Diego State University. By 22, he'd earned both bachelor's and master's degrees. As a young man trailblazing a path in a landscape that needed evolution, he knew he was called to help create better healthcare systems than those that had let down the people he loved most in the past. But where to start? The Pulse Oximeter That Changed Everything That question found its answer inside the halls of a hospital. He found himself working with pulse oximeters, devices that measure blood oxygen, and quickly noticed something troubling. They weren't accurate when patients moved or had low perfusion. This wasn't a minor issue, lives were at stake. Kiani knew there had to be a better way. In 1989, he founded Masimo from his garage with a vision: create patient-monitoring technology that worked in real-world conditions. After years of trial and error, he developed Signal Extraction Technology® (SET®) a breakthrough that dramatically improved the accuracy of pulse oximetry. "Every sleepless night taught me this: when your mission is urgent, setbacks become fuel," added Kiani. Today, Masimo devices are used in hospitals worldwide and have helped prevent countless deaths. Fighting for Transparency and Accountability Innovation, however, was only half the battle. Kiani quickly encountered resistance from entrenched interests in the medical device industry. He was outspoken about unethical practices, from hidden pricing to anti-competitive behavior, and he didn't hesitate to name names. "Healthcare injustice doesn't wear a villain's face, it hides in forms, denials, and board rooms and waiting rooms. We need to pull it into the light," he added. That conviction led him to found the Patient Safety Movement Foundation in 2012. Its bold goal: achieve zero preventable deaths in hospitals by uniting clinicians, tech companies, and policymakers. The foundation pushed hospitals to adopt actionable patient safety goals and urged companies to share data, an effort Kiani personally led by convincing dozens of manufacturers to open up their proprietary systems. "It's one thing to build products that monitor life. It's another to remember the lives behind every data point. That's the heart of it all," he said. An Immigrant Champion for Inclusion Kiani's commitment to justice extends beyond medicine. As an immigrant who faced his share of hurdles, he is a vocal advocate for diversity in corporate leadership. Under his guidance, he has built teams and policies to foster inclusion and transparency. Kiani believes that diversity is not just ethical, it's strategic. "When people from different backgrounds collaborate, you get better ideas. More empathy. More breakthroughs," he said. Like Minded Labs and the Future of Connection Beyond his contributions to the healthcare industry, Kiani is exploring new frontiers. His latest venture, as CEO of Like Minded Labs, is aimed at enhancing human connection in an increasingly digital world. While details remain under wraps, the mission is clear: use technology to enrich human interactions. Purpose Over Profit Through every chapter of his life, Kiani's North Star has remained the same: impact. "Some people see leadership as power. I see it as responsibility, to amplify good ideas, protect your team's courage, and walk the path of truth even when it's inconvenient," he said. Joe Kiani's journey, from immigrant youth to tech visionary, is not just about building devices. It's about building a better, fairer, safer world. And for him, the work is far from over.
